arrow
A

Ali Dabbagh

Shahid Beheshti University Medical Sciences
H指数:24
被引数:2,958

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trans-Catheter Aortic Valve Replacement (AVR) in Severe Aortic Stenosis: A 3-year Experience in Modarres Hospital (A Tertiary University Hospital, Tehran, Iran)

经导管主动脉瓣置换术(AVR)在严重主动脉瓣狭窄中的应用:莫达雷斯医院(德黑兰,伊朗一家三级大学医院)3年经验

2025-12-010
PRE
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
2023-05-124
OA
Molecular basis of rare congenital bleeding disorders

罕见先天性出血性疾病的分子基础

2023-05-0115
PRE
Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial
2023-05-010
PRE
Machine Learning To Identify Heterogeneity Of Treatment Effect Of Intermediate-dose Vs Standard-dose Prophylactic Anticoagulation In The Inspiration Trial
2023-05-010
PRE
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
2021-06-0659
OAAI
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
2021-04-27487
OA
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
2020-12-0151
OAAI
Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?

先天性出血性疾病患者似乎受SARS-CoV-2影响较小: 遗传性低凝性是否克服了冠状病毒性疾病的获得性高凝性2019 (新型冠状病毒肺炎)?

2020-06-1822
OAAI